Japanese Orthopedic Biomaterials Market
The Japanese orthopedic biomaterials market is expected to approach $1.5 billion by 2019. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Japanese orthopedic biomaterials market.
The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented only into synthetics) and hyaluronic acid (HA) viscosupplementation. Although the market has reached maturity in Japan, it is expected to continue to grow as a result of the large aging population. Further growth in the overall market will be fuelled by the increased value of the HA viscosupplementation segment. This is due to the continued use of premium priced three-injection cycle products in Japan that were introduced in December 2010.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for Japan.
Others include: Biomet, JMDM, Mizuho, NGKNTK, Stryker, Zimmer and local Japanese pharmaceutical companies.
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented only into synthetics) and hyaluronic acid (HA) viscosupplementation. Although the market has reached maturity in Japan, it is expected to continue to grow as a result of the large aging population. Further growth in the overall market will be fuelled by the increased value of the HA viscosupplementation segment. This is due to the continued use of premium priced three-injection cycle products in Japan that were introduced in December 2010.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for Japan.
Others include: Biomet, JMDM, Mizuho, NGKNTK, Stryker, Zimmer and local Japanese pharmaceutical companies.
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
EXECUTIVE SUMMARY
1.1 JAPAN MARKET FOR ORTHOPEDIC BIOMATERIALS
1.2 GROWTH TRENDS BY SEGMENT
1.3 BONE GRAFT SUBSTITUTE MARKET
1.4 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.5 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
JAPANESE ORTHOPEDIC BIOMATERIALS MARKET
3.1 INTRODUCTION
3.1.1 Growth Factors
3.1.2 Bone Graft Substitutes
3.1.3 Hyaluronic Acid Viscosupplementation
3.2 CURRENCY EXCHANGE RATE
3.3 PROCEDURES
3.3.1 Total Orthopedic Bone Graft Substitute Procedures by Segment
3.3.2 Total Orthopedic Bone Graft Substitute Procedures by Indication
3.3.3 Bone Graft Substitute Procedures
3.3.4 Hyaluronic Acid Viscosupplementation Procedures
3.4 MARKET OVERVIEW
3.5 TREND ANALYSIS
3.6 MARKET DRIVERS AND LIMITERS
3.6.1 Market Drivers
3.6.2 Market Limiters
3.7 COMPETITIVE ANALYSIS
3.7.1 Leading Competitors
3.8 MERGERS AND ACQUISITIONS
BONE GRAFT SUBSTITUTE MARKET
4.1 INTRODUCTION
4.1.1.1 Autograft
4.1.1.2 Non-Proprietary Allograft
4.1.1.3 Demineralized Bone Matrix
4.1.1.4 Synthetic
4.1.2 Volumes Represented per Procedure
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS & FORECAST
4.3.1 Bone Graft Substitute Market by Material
4.3.1.1 Synthetic Market
4.3.2 Bone Graft Substitute Market by Indication
4.3.2.1 Cervical Spine Market
4.3.2.2 Thoracolumbar Spine Market
4.3.2.3 Trauma & Reconstruction Market
4.3.2.4 Craniomaxillofacial Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
5.1 INTRODUCTION
5.1.1.1 Single-Injection Products
5.1.1.2 Three-Injection Cycle Products
5.1.1.3 Five-Injection Cycle Products
5.2 MARKET OVERVIEW
5.2.1 Hyaluronic Acid (HA) Viscosupplementation Market by Segment
5.3 MARKET ANALYSIS & FORECAST
5.3.1.1 Three-Injection Cycle Market
5.3.1.2 Five-Injection Cycle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
1.1 JAPAN MARKET FOR ORTHOPEDIC BIOMATERIALS
1.2 GROWTH TRENDS BY SEGMENT
1.3 BONE GRAFT SUBSTITUTE MARKET
1.4 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.5 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
JAPANESE ORTHOPEDIC BIOMATERIALS MARKET
3.1 INTRODUCTION
3.1.1 Growth Factors
3.1.2 Bone Graft Substitutes
3.1.3 Hyaluronic Acid Viscosupplementation
3.2 CURRENCY EXCHANGE RATE
3.3 PROCEDURES
3.3.1 Total Orthopedic Bone Graft Substitute Procedures by Segment
3.3.2 Total Orthopedic Bone Graft Substitute Procedures by Indication
3.3.3 Bone Graft Substitute Procedures
3.3.4 Hyaluronic Acid Viscosupplementation Procedures
3.4 MARKET OVERVIEW
3.5 TREND ANALYSIS
3.6 MARKET DRIVERS AND LIMITERS
3.6.1 Market Drivers
3.6.2 Market Limiters
3.7 COMPETITIVE ANALYSIS
3.7.1 Leading Competitors
3.8 MERGERS AND ACQUISITIONS
BONE GRAFT SUBSTITUTE MARKET
4.1 INTRODUCTION
4.1.1.1 Autograft
4.1.1.2 Non-Proprietary Allograft
4.1.1.3 Demineralized Bone Matrix
4.1.1.4 Synthetic
4.1.2 Volumes Represented per Procedure
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS & FORECAST
4.3.1 Bone Graft Substitute Market by Material
4.3.1.1 Synthetic Market
4.3.2 Bone Graft Substitute Market by Indication
4.3.2.1 Cervical Spine Market
4.3.2.2 Thoracolumbar Spine Market
4.3.2.3 Trauma & Reconstruction Market
4.3.2.4 Craniomaxillofacial Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
5.1 INTRODUCTION
5.1.1.1 Single-Injection Products
5.1.1.2 Three-Injection Cycle Products
5.1.1.3 Five-Injection Cycle Products
5.2 MARKET OVERVIEW
5.2.1 Hyaluronic Acid (HA) Viscosupplementation Market by Segment
5.3 MARKET ANALYSIS & FORECAST
5.3.1.1 Three-Injection Cycle Market
5.3.1.2 Five-Injection Cycle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
